TY  - JOUR
AU  - Sastre-Heres, Alejandro J
AU  - Alaguero Calero, Miguel
AU  - Ruiz-Sánchez, Daniel
AU  - Iglesias García, María Teresa
AU  - Calleja Hernandez, Miguel Angel
AU  - Martínez Martínez, Fernando
AU  - Peña-Díaz, Jaime
PY  - 2014
DO  - 10.3892/mco.2014.353
SN  - 2049-9450
UR  - http://hdl.handle.net/10668/1933
T2  - Molecular and Clinical Oncology
AB  - The emergence of novel drugs corresponds with the determination of the effectiveness of the current treatments used in clinical practice. A retrospective observational study was conducted to evaluate the effectiveness of first-line treatments and to...
LA  - en
PB  - Spandidos Publications
KW  - Renal cell cancer
KW  - Effectiveness
KW  - Sunitinib
KW  - Temsirolimus
KW  - Prognosis
KW  - Resultado del Tratamiento
KW  - Antineoplásicos
KW  - Inhibidores de la Angiogénesis
KW  - Carcinoma de Células Renales
KW  - Pronóstico
KW  - Supervivencia
KW  - Estudio Observacional
KW  - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Kidney Neoplasms::Carcinoma, Renal Cell
KW  - Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents
KW  - Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Growth Substances::Angiogenesis Modulating Agents::Angiogenesis Inhibitors
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Survival Analysis
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Clinical Trials as Topic::Observational Study as Topic
TI  - Study of the effectiveness of first-line treatment in renal cell carcinoma.
TY  - research article
ER  -